Literature DB >> 16675524

Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation.

Janine P Woodrow1, Christopher J Sharpe, Neva J Fudge, Ana O Hoff, Robert F Gagel, Christopher S Kovacs.   

Abstract

The maternal skeleton rapidly demineralizes during lactation to provide calcium to milk, responding to the stimuli of estrogen deficiency and mammary-secreted PTH-related protein. We used calcitonin/calcitonin gene-related peptide-alpha (Ctcgrp) null mice to determine whether calcitonin also modulates lactational mineral metabolism. During 21 d of lactation, spine bone mineral content dropped 53.6% in Ctcgrp nulls vs. 23.6% in wild-type (WT) siblings (P < 0.0002). After weaning, bone mineral content returned fully to baseline in 18.1 d in Ctcgrp null vs. 13.1 d in WT (P < 0.01) mice. Daily treatment with salmon calcitonin from the onset of lactation normalized the losses in Ctcgrp null mice, whereas calcitonin gene-related peptide-alpha or vehicle was without effect. Compared with WT, Ctcgrp null mice had increased circulating levels of PTH and up-regulation of mammary gland PTH-related protein mRNA. In addition, lactation caused the Ctcgrp null skeleton to undergo more trabecular thinning and increased trabecular separation compared with WT. Our studies confirm that an important physiological role of calcitonin is to protect the maternal skeleton against excessive resorption and attendant fragility during lactation and reveal that the postweaning skeleton has the remarkable ability to rapidly recover even from losses of over 50% of skeletal mineral content.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675524     DOI: 10.1210/en.2005-1616

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  37 in total

1.  Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.

Authors:  Bryan R Becklund; Donald W Hansen; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

Review 2.  Presentation and management of osteoporosis presenting in association with pregnancy or lactation.

Authors:  C S Kovacs; S H Ralston
Journal:  Osteoporos Int       Date:  2015-05-05       Impact factor: 4.507

3.  Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton.

Authors:  Laleh Ardeshirpour; Susan Brian; Pamela Dann; Joshua VanHouten; John Wysolmerski
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

4.  Reproductive hormones and skeletal health in young women.

Authors:  Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

5.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

6.  FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.

Authors:  Yue Ma; Beth J Kirby; Nicholas A Fairbridge; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

7.  Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.

Authors:  Yue Ma; Manoharee Samaraweera; Sandra Cooke-Hubley; Beth J Kirby; Andrew C Karaplis; Beate Lanske; Christopher S Kovacs
Journal:  Endocrinology       Date:  2014-03-06       Impact factor: 4.736

8.  Intrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal Cells.

Authors:  Beth Bragdon; Robert Burns; Amelia H Baker; Anna C Belkina; Elise F Morgan; Gerald V Denis; Louis C Gerstenfeld; Jennifer J Schlezinger
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

9.  Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats.

Authors:  Panan Suntornsaratoon; Kannikar Wongdee; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2009-09-17       Impact factor: 2.781

10.  Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study.

Authors:  Janaka Lenora; Sarath Lekamwasam; Magnus K Karlsson
Journal:  BMC Womens Health       Date:  2009-07-01       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.